MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

Headless AG Grid server for advanced data visualization, manipulation, and export, seamlessly integrated with Claude Desktop. - heyhaiden/mcp-ag-grid ...

Here is the latest in the rider line-up for the 2026 MotoGP season - plus the latest rumours about what might be next... Ducati Ducati’s “dream team” factory Lenovo line-up of Francesco ...